Xingqiang Wang

Papers

Total Citations

H-Index

About

Xingqiang Wang is a leading clinical researcher in surgical oncology, with a primary focus on minimally invasive approaches to gastric cancer treatment. His work is centrally concerned with evaluating the safety and efficacy of robotic-assisted surgical techniques, particularly robotic distal gastrectomy, compared to conventional methods. Wang’s most notable contribution is a comprehensive systematic review and meta-analysis, published in 2022, which synthesized data from multiple studies to assess clinical outcomes—including operative time, blood loss, lymph node dissection, and postoperative recovery—in gastric cancer patients. This meta-analysis, which has garnered over 30 citations, provides critical evidence supporting the feasibility and potential advantages of robotic surgery, while also highlighting areas requiring further investigation. By rigorously analyzing pooled data, Wang has helped clarify the role of robotic platforms in complex gastrointestinal procedures, offering surgeons and oncologists a clearer framework for decision-making. His work is particularly valuable for researchers and clinicians navigating the transition from laparoscopic to robotic techniques, and it underscores his commitment to evidence-based surgical innovation. Through this high-impact synthesis, Wang has established himself as a key voice in the ongoing debate over optimal surgical strategies for gastric cancer.